CRISPR Therapeutics vs DiaMedica Therapeutics
CRISPR Therapeutics vs DiaMedica Therapeutics, compared side by side on 18 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: CRISPR Therapeutics is on 64/100 and DiaMedica Therapeutics on 35/100.
Where each one leads
CRISPR Therapeutics
- our overall score: 64/100 against 35/100
- domain rating: 67/100 against 34/100
- funding raised: $547M against $30.1M
DiaMedica Therapeutics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | CRISPR Therapeutics | DiaMedica Therapeutics |
|---|---|---|
| What it is | Biotechnology company developing transformative gene-based medicines using CRISPR/Cas9 gene editing technology. | Clinical-stage biopharmaceutical company developing novel treatments for serious ischemic and vascular diseases. |
| Category | Biotechnology, Gene Editing, Therapeutics, Pharmaceuticals | Biotechnology, Healthcare, Pharmaceuticals |
| Sells toBusiness model | B2B | B2B |
| Offering | Platform | Biopharmaceutical |
| Founded | 2013 | 2000 |
| Headquarters | Zug, Switzerland | Minneapolis, United States |
| Status | Active | Active |
Size, funding and growth
| Measure | CRISPR Therapeutics | DiaMedica Therapeutics |
|---|---|---|
| Total funding | $547M | $30.1M |
| Latest round | Series B | Private Placement |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | CRISPR Therapeutics | DiaMedica Therapeutics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 64/100 | 35/100 |
| Traction | 40/100 | 37/100 |
| Team | 70/100 | Not published |
| Search visibility | 13/100 | 11/100 |
| Quality | 88/100 | 45/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (44/100) | D (47/100) |
| Domain ratingLink authority, 0-100 | 67/100 | 34/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | CRISPR Therapeutics | DiaMedica Therapeutics |
|---|---|---|
| Hosting | Self Managed | AWS |
| Frameworks | Jquery | Bootstrap |
| Analytics | Google Analytics 4 | Google Analytics 4 |
CRISPR Therapeutics vs DiaMedica Therapeutics: common questions
Which is better, CRISPR Therapeutics or DiaMedica Therapeutics?
On our 0-100 score CRISPR Therapeutics rates higher (64/100 against 35/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 18 data points above: read the rows that match what you are buying for.
How do CRISPR Therapeutics and DiaMedica Therapeutics compare on the numbers?
CRISPR Therapeutics leads on our overall score (64/100 against 35/100), domain rating (67/100 against 34/100), funding raised ($547M against $30.1M).
Read the full CRISPR Therapeutics review and pricing or the DiaMedica Therapeutics review and pricing. You can also browse other CRISPR Therapeutics alternatives we track.